RPM - Biotechnology

Turn Scientific Discoveries into Breakthrough Innovations.

Our biotech R&D project management framework integrates Critical Chain Project Management (CCPM) with a structured stage-gate methodology to manage complex research and development programs. It enables teams to evaluate progress through predefined decision gates, where projects can be approved, discontinued, sent for rework, or redirected based on scientific outcomes, technical feasibility, and business priorities. A flexible stage-gate structure supports the entire product lifecycle, from initial concept assessment and feasibility studies to development, analytical method validation, stability testing, scale-up, regulatory submissions, and commercial launch. Each stage is governed by measurable deliverables, documented reviews, and traceable approval workflows.

By eliminating excessive task-level safety margins and consolidating time protection into stage and project buffers, the framework improves schedule reliability across interconnected discovery, development, analytical, regulatory, and quality assurance activities. Resource dependencies and competing demands across multiple programs are managed through critical-chain scheduling, while buffer monitoring highlights emerging risks and schedule pressure early. This allows R&D leaders to intervene before delays cascade through the pipeline, helping teams maintain regulatory submission commitments, optimize resource utilization, and achieve more predictable development and launch timelines.

CORE Platform features for Stage-Gate CCPM

The Stage-Gate CCPM platform digitizes the complete biotech R&D program lifecycle — from configurable stage and gate workflows to critical chain scheduling, buffer management, and portfolio reporting. It provides a structured, measurable, and traceable approach to program development while enabling continuous improvement across the development pipeline.

Stage-Gate & Governance

Configurable N-gate models for biotech programs, with gate-specific checklists of deliverables, data, and approvals, reviewer-defined sign-off sequencing, go, kill, rework, and redirect decisions, and rejection reason codes. Stage and gate templates by program type and market, with version-controlled definitions that keep in-flight programs intact when WBS and SOPs change.

Critical Chain Scheduling

Identifies the critical chain through resource-constrained scheduling across parallel workstreams such as development, analytical, and regulatory work, with CPM and CCPM views available at any time. Task-level median durations and ranges, plus full-kit readiness checks and relay-race execution, keep work moving without hand-off delays.

Buffer Management

Tracks stage and project buffers using fever charts with green and red zones per program and across the pipeline. Buffer penetration alerts automatically flag red-zone tasks to the R&D head so recovery action starts before delays reach the critical chain.

Sprint-Based Execution

Work runs one stage at a time. Stage activities start in a backlog and are divided into sprints, each with a planned duration in days, planned effort in hours, and a material budget, assigned to a named team member. Gate rework lets the team reset all or selected activities and resubmit for approval.

Budget, Hours & Material Tracking

Timesheets update hours across the system automatically, and budget-versus-actual variance is tracked for hours and material by stage. Material requisitions and consumption, including lab consumables, are tagged to activities and integrated with SAP.

Collaboration, Access & Security

Role-based task assignment across R&D, QA, QC, Regulatory, Manufacturing, Procurement, and Supply Chain, with to-dos and issues tracked to closure and AI-summarized project notes. Role-based access control with granular permissions, an event log of user actions, an escalation matrix for overdue items, and multi-site, multi-BU configuration.

Document & Master Data Management

Project documents are tagged with structured metadata such as product, gate, study type, and version for fast retrieval. Molecule, asset, facility, and item masters sit alongside, with available stock viewed from SAP.

Biotech R&D & Portfolio Analytics

Extends scheduling to resource capacity planning across development, analytical, regulatory, and QA teams, with a gate-stage heatmap of the full program pipeline, budget-versus-actual variance for hours and material, NPV-based feasibility analysis, and milestone and launch-date rollups for management and board review.

Benefits of SG-CCPM

1. Protect Filing and Launch Dates, Not Just Task Dates

Manage the product pipeline through pooled buffers rather than individual task deadlines, catching delays before they hit the critical chain and push out a regulatory filing or launch.

2. Reduce Resource Contention

Plan capacity across formulation, analytical, regulatory, and QA teams and shared facilities for concurrent products, eliminating the multitasking that silently stalls development.

3. Standardize Go/Kill Decisions

Apply consistent gate checklists, sign-off workflows, and decision outcomes — go, kill, rework, or redirect — across products, portfolios, and sites, replacing ad hoc reviews with structured, auditable decisions.

4. Bridge R&D to Filing and Launch

Carry each product from formulation through ANDA, DMF, or CTD filing to commercial launch, with tagged project documents for fast retrieval and material requisitions and consumption integrated with SAP.

Book a Demo

Schedule a personalized demo with our team

Frequently Asked Questions

Everything you need to know about the SG-CCPM platform.

The platform is designed for R&D departments in generic pharmaceutical companies, where parallel workstreams such as API sourcing, formulation, analytical development, and regulatory preparation compete for shared teams and facilities, creating scheduling bottlenecks that standard project tools don't address.

CCPM identifies the true critical chain — accounting for both technical dependencies and resource contention — then protects it using pooled stage and project buffers instead of task-level padding, removing the Parkinson's Law delays and multitasking losses common in pharma development.

Stage-gate provides the phase structure and go/kill/rework/redirect governance — concept through commercial launch — while CCPM manages scheduling and resourcing within and across stages, so gate decisions are backed by real buffer and resource data rather than optimistic task estimates.

Buffers are visualized using fever charts with green and red zones for each project and across the portfolio. Buffer penetration alerts automatically flag red-zone tasks to the R&D head so recovery action can begin early.

The platform supports resource capacity planning across formulation, analytical, regulatory, and QA teams. Every activity is assigned to a specific person with planned duration, effort, and material budget, and assignees see their work in the project dashboard and activity tab, with timesheets updating hours across the system.

Yes. Stage and gate templates can be set up by product complexity — such as simple oral solids versus complex injectables or biosimilars — and by market, including US ANDA, EU, rest of world, and domestic. Projects can be saved to and loaded from templates, and the WBS and gate criteria can still be adjusted for each project.

The solution provides dashboards for projects by stage and gate, portfolio view, stage-wise Gantt timelines, budget variance in hours and material, buffer usage by stage, project analytics, and NPV analysis, plus milestone and launch-date reporting for management.

Yes. Material requisitions and consumption can be tagged to project activities and integrated with SAP, and item inventory screens show updated available stock from SAP.

Yes. The platform supports single-product projects as well as multi-site, multi-business-unit pharma R&D portfolios, with configurable workflows, role-based access control, granular permissions, and an escalation matrix for overdue and delayed items.